Live feed
Filing
SC 13G/A
SC 13G/A0001354488-15-002822·DAILEY ROBERT JACKMAN
Schedule 13G ownership disclosure
Immune Therapeutics Inc
Security class unavailable · CUSIP: 45252A107
Event date: 2015-02-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 10,497,262
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001354488-15-002822
- Form type
- SC 13G/A
- Filer
- DAILEY ROBERT JACKMAN
- CIK
- CIK 1570523
- Filed
- Jun 02, 2015
- Reporting period
- Feb 14, 2015
- Description
- Schedule 13G beneficial ownership